Cargando…
Tumor microenvironment-responsive DNA-based nanomedicine triggers innate sensing for enhanced immunotherapy
Lack of proper innate sensing inside the tumor microenvironment could reduce both innate and adaptive immunity, which remains a critical cause of immunotherapy failure in various tumor treatments. Double-stranded DNA (dsDNA) has been evidenced to be a promising immunostimulatory agent to induce type...
Autores principales: | Li, Jinyang, Han, Xiaoyu, Gao, Shanshan, Yan, Yumeng, Li, Xiaoguang, Wang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585899/ https://www.ncbi.nlm.nih.gov/pubmed/37858171 http://dx.doi.org/10.1186/s12951-023-02132-6 |
Ejemplares similares
-
Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
por: Peng, Shaojun, et al.
Publicado: (2021) -
Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
por: Xu, Yanyan, et al.
Publicado: (2022) -
Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy
por: Mpekris, Fotios, et al.
Publicado: (2022) -
Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery
por: Zhang, Bo, et al.
Publicado: (2017) -
Nanomedicines targeting activation of STING to reshape tumor immune microenvironment and enhance immunotherapeutic efficacy
por: Chen, Shanshan, et al.
Publicado: (2023)